Evidence map›Paper›PMID 31485640›Full record

ArticleMolecular medicine reports2019

[Corrigendum] Effects of the Tangningtongluo formula as an alternative strategy for diabetics via upregulation of insulin receptor substrate-1.

Long Cheng, Junmei Song, Geng Li, Yue Liu, Yuming Wang, Xiangbao Meng, Guibo Sun, Xiaobo Sun

Abstract readPublished Erratum
In one paragraph

Article in Molecular medicine reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Long ChengPharmacology and Toxicology Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, P.R. China.
Junmei SongDepartment of Clinical Pharmacy, Baoji People's Hospital, Baoji, Shaanxi 721000, P.R. China.
Geng LiIntegrative Medicine Center for Cardiovascular Disease, China‑Japan Friendship Hospital, Beijing 100029, P.R. China.
Yue LiuCardiovascular Disease Centre, Xiyuan Hospital, China Academy of Traditional Chinese Medicine, Beijing 100091, P.R. China.
Yuming WangDepartment of Oncology, The Affiliated Hospital of Chifeng University, Chifeng, Inner Mongolia 024005, P.R. China.
Xiangbao MengPharmacology and Toxicology Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, P.R. China.
Guibo SunPharmacology and Toxicology Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, P.R. China.
Xiaobo SunPharmacology and Toxicology Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subsequently to the publication of this article, the authors have realized that Fig. 4 contained some incorrectly incorporated data panels; specifically, the A‑d, B‑b and B‑c panels did not display the correct data. The revised version of Fig. 4 featuring the correct data for the A‑d, B‑b and B‑c panels is shown on the next page. Note that these errors did not affect the overall conclusions reported in the paper. The authors apologize to the Editor of Molecular Medicine Reports and to readership for any inconvenience caused. [the original article was published in Molecular Medicine Reports 16: 703‑709, 2017; DOI: 10.3892/mmr.2017.6679].

Identifiers

PMID31485640
PMCPMC6797940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.